The Peptide Craze Ground Truths FDA to weigh easing limits on unproven peptides promoted by RFK Jr. BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved BPC 157 What Athletes Need to Know About Legality, Safety and Efficacy Training & Conditioning BPC 157: The peptide with big claims and scant evidence STAT The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York